4//SEC Filing
Dorling Janet 4
Accession 0001333277-21-000035
CIK 0001042074other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:00 PM ET
Size
5.3 KB
Accession
0001333277-21-000035
Insider Transaction Report
Form 4
Dorling Janet
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-05+80,000→ 80,000 totalExercise: $4.63Exp: 2031-04-04→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/36 of the underlying shares monthly from April 5, 2021.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001738144
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:00 PM ET
- Size
- 5.3 KB